Success Story: EB-2 NIW Approval After RFE for a Biomedical Science Researcher Advancing Drug Development for Major Human Diseases
Client’s Testimonial:
"Thank you again to everyone involved in my case. I greatly appreciate your hard work and dedication throughout this process.”
On May 28th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Graduate Research Assistant
Approval Notice Date: May 28th, 2026
Processing Time: 26 months, 6 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group is pleased to share the approval of an I-140 National Interest Waiver petition for a biomedical science researcher whose work focuses on elucidating disease mechanisms and developing new therapeutic approaches for major human diseases, including obesity, cancer, infectious diseases, and other serious health conditions.
At the time of filing, the client, who received a M.Sc. in biotechnology, was conducting biomedical research at a U.S. research institution and planned to continue advancing work related to new therapeutic strategies, including research involving targeted approaches for cancer treatment. This current research role helped demonstrate the client’s continued commitment to the proposed endeavor and ability to keep contributing to the biomedical science field in the United States.
The petition showed that the client’s work has both substantial merit and national importance. We explained that the client’s research supports efforts to better understand disease mechanisms and develop improved drugs for conditions that affect large populations in the United States and worldwide. The petition also connected the client’s work to biotechnology, an area recognized as important to U.S. scientific and technological leadership.
The client’s research record included:
- 7 peer-reviewed journal articles, including 3 first-authored articles
- 67 citations to published research
- Evidence of support from major research funding sources
A central strength of this case was the way the petition demonstrated the client’s significance through objective evidence of field-wide reliance. Rather than relying only on publication numbers, the petition explained how independent researchers had cited and applied the client’s findings in later studies related to obesity mechanisms, fat metabolism, molecular signaling pathways, and potential therapeutic targets.
The petition highlighted several areas of the client’s contributions, including research on natural compounds with anti-obesity effects, the use of an existing anti-inflammatory drug to better understand obesity-related mechanisms, and the role of a protein involved in fat and muscle metabolism.
Overall, the petition established that the client was well-positioned to advance the proposed endeavor by presenting the client’s advanced education, specialized biomedical research background, publication record, citation impact, evidence of influential research, funding support, and clear future research plans. The filing also showed that the client’s work has practical relevance to public health and drug development, making the waiver of the job offer and labor certification requirements beneficial to the United States.
We congratulate the client on this EB-2 NIW approval after receiving RFE and look forward to the client’s continued contributions to biomedical science, therapeutic development, and research addressing major human diseases.